Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients (2022)
- Authors:
- USP affiliated authors: ROCHA, VANDERSON GERALDO - FM ; COSTA, SILVIA FIGUEIREDO - FM
- Unidade: FM
- DOI: 10.3390/antibiotics11091269
- Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS; CÉLULAS-TRONCO; TRANSPLANTE DE MEDULA ÓSSEA
- Language: Inglês
- Imprenta:
- Source:
- Título: Antibiotics-basel
- ISSN: 2079-6382
- Volume/Número/Paginação/Ano: v. 11, n. 9, article ID 1269, 8p, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
GUIMARAES, Thais et al. Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients. Antibiotics-basel, v. 11, n. 9, 2022Tradução . . Disponível em: https://doi.org/10.3390/antibiotics11091269. Acesso em: 28 dez. 2025. -
APA
Guimaraes, T., Borges, I. C., Spadao, F. de S., Mariano, L., Nascimento, M. de M., Higashino, H., et al. (2022). Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients. Antibiotics-basel, 11( 9). doi:10.3390/antibiotics11091269 -
NLM
Guimaraes T, Borges IC, Spadao F de S, Mariano L, Nascimento M de M, Higashino H, Rossi F, Rocha VG, Costa SF. Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients [Internet]. Antibiotics-basel. 2022 ; 11( 9):[citado 2025 dez. 28 ] Available from: https://doi.org/10.3390/antibiotics11091269 -
Vancouver
Guimaraes T, Borges IC, Spadao F de S, Mariano L, Nascimento M de M, Higashino H, Rossi F, Rocha VG, Costa SF. Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients [Internet]. Antibiotics-basel. 2022 ; 11( 9):[citado 2025 dez. 28 ] Available from: https://doi.org/10.3390/antibiotics11091269 - COVID-19 in hematopoietic stem-cell transplant recipients: a systematic review and meta-analysis of clinical characteristics and outcomes
- Evaluation of Dengue, Zika virus, and Chikungunya virus transmission by blood components in recipients of haematopoietic stem cell transplantation
- Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay
- Colonization by Extended-Spectrum β-Lactamase-Producing Enterobacterales and Bacteremia in Hematopoietic Stem Cell Transplant Recipients
- Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization
- COVID-19 surveillance in a bone marrow transplantation unit: experience from a Brazilian tertiary-care teaching hospital
- Fatal hepatic mucormycosis in an allogeneic hematopoietic-stem cell transplanted patient: case report of a rare presentation and review of the literature
- Genetic description of VanD phenotype vanA genotype in vancomycin-resistant Enterococcus faecium isolates from a Bone Marrow Transplantation Unit
- COVID-19 in hematopoietic stem cell transplant recipients during three years of the pandemic: a multicenter study in Brazil
- A case-series of Toxoplasmosis in hematopoietic stem cell transplantation [Carta]: still a concern for endemic countries
Informações sobre o DOI: 10.3390/antibiotics11091269 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
